This study will validate the efficacy and safety of the VESTO® Vascular Stent for treating patients with iliac peripheral arterial obstructive disease in a post-market clinical trial
18 years of age or older;
TASC-II aortoiliac lesion classification of modified class A, B, C, or D;
Rutherford classification score of 2 to 5;
Access site compatibility with the device delivery system;
Known hypersensitivity to heparin, contrast media, or stent components;
Patient with blood dyscrasia;
Pregnant or breastfeeding women;
Patient currently participating in an investigational drug or device study;